secwatch.observer — SEC 8-K summary
======================================

Issuer:     JOHNSON & JOHNSON (JNJ)
CIK:        0000200406
Form:       8-K
Filed at:   2026-08-04T12:48:52+00:00
Accession:  0000200406-26-000167
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Jennifer Taubert, EVP and Worldwide Chairman of Innovative Medicine, to retire Sept 1, 2026
--------------------------------------------------------------------------------

- Jennifer Taubert retiring as EVP, Worldwide Chairman of Innovative Medicine and member of Executive Committee.
- Retirement effective September 1, 2026.
- No successor has been named at this time.
- Announcement made on August 4, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/200406/000020040626000167/0000200406-26-000167-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/200406/000020040626000167/jnj-20260804.htm
  HTML page:      https://secwatch.observer/filing/0000200406-26-000167

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer